Please use this identifier to cite or link to this item:
|Title:||Nanopharmaceuticals Regulatory Aspects and Safety Issues|
|Citation:||CHEMANAGER EUROPE no. 7 p. 18|
|Publisher:||GIT VERLAG (WILEY)|
|Type:||Articles in periodicals and books|
|Abstract:||Applications of nanotechnology in the pharmaceutical industry will have to conform to stringent criteria regarding public health, safety and environmental protection. While the existing European regulatory framework appears sufficient to deal with nanotechnology at its present state of development, review of the existing regulations may be necessary to ensure they adequately protect human health and the environment. Assessment of the health and environmental risks of nanoparticles should focus particular attention on the influence of particle size and surface chemistry on potential adverse effects.|
|JRC Institute:||Institute for Environment and Sustainability|
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.